secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLESENCE, INC. (SLSN)
CIK:        0000883107
Form:       8-K
Filed at:   2021-08-17T23:59:59+00:00
Accession:  0001171843-21-006007
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nanophase reports record Q2 revenue of $7.1M; Solésence beauty science revenue up 210% YoY to $8.8M in H1
--------------------------------------------------------------------------------

- Record Q2 revenue $7.1M vs $4.3M in Q2 2020 (YoY +65%).
- H1 2021 revenue $14.2M (+69% YoY); net income $1.4M compared to $0.4M.
- Solésence beauty science H1 revenue $8.8M, up 210% from $2.8M, exceeding full-year 2020.
- PPP loan $1.0M forgiven by SBA; non-cash interest $0.9M from conversion of related party loan.
- Cash at quarter end $1.1M; purchase orders >$20M, half expected to ship in H2 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883107/000117184321006007/0001171843-21-006007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883107/000117184321006007/f8k_081421.htm
  HTML page:      https://secwatch.observer/filing/0001171843-21-006007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer